Description: Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. The company offers syrup and powder versions of Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke used in various foods, beverages, and dietary supplement formats. It also provides Fruitflow+ Omega-3, a dietary supplement product. The company sells its products through company's website and distributors. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.
Home Page: www.provexis.com
2 Blagrave Street
Reading,
RG1 1AZ
United Kingdom
Phone:
44 7490 391888
Officers
| Name | Title |
|---|---|
| Mr. Ian Ford BA (Hons) ACA, F.C.A. | CEO, CFO, Company Secretary & Executive Director |
| Dr. Niamh Ann O'Kennedy B.Sc., BSc, M.Sc., MSc, Ph.D. | Chief Scientific Officer, Member of Scientific Advisory Board & Executive Director |
| Prof. Asim K. Duttaroy BS MS Ph.D., DSc FICN | Consultant & Member of Scientific Advisory Board |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.296 |
| Price-to-Sales TTM: | 22.2619 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 2 |